Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
Go back to Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results| (NASDAQ: LRMR) | Delayed: 2.75 -0.03 (1.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.78 | 52 Week High | $ | |||
| Open | $2.77 | 52 Week Low | $ | |||
| Day High | $2.84 | P/E | N/A | |||
| Day Low | $2.72 | EPS | $ | |||
| Volume | 717,993 | |||||



